Price$1.21-0.08 (-6.20%)
01:30 PM07:45 PM
News · 26 weeks23-50%
2025-12-142026-06-07
Mix1090d
- SEC Filings8(80%)
- Other2(20%)
Latest news
25 items- SECSEC Form 10-Q filed by XWELL Inc.10-Q - XWELL, Inc. (0001410428) (Filer)
- SECSEC Form NT 10-Q filed by XWELL Inc.NT 10-Q - XWELL, Inc. (0001410428) (Filer)
- SECAmendment: SEC Form 10-K/A filed by XWELL Inc.10-K/A - XWELL, Inc. (0001410428) (Filer)
- SECSEC Form 424B3 filed by XWELL Inc.424B3 - XWELL, Inc. (0001410428) (Filer)
- SECSEC Form EFFECT filed by XWELL Inc.EFFECT - XWELL, Inc. (0001410428) (Filer)
- SECAmendment: XWELL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K/A - XWELL, Inc. (0001410428) (Filer)
- SECSEC Form S-3 filed by XWELL Inc.S-3 - XWELL, Inc. (0001410428) (Filer)
- SECXWELL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - XWELL, Inc. (0001410428) (Filer)
- PRXWELL Reports Fiscal 2025 ResultsNEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced financial results for the year ended December 31, 2025. Recent Operating Highlights XWELL delivered 2025 revenue of approximately $29.2 million.Total operating expenses decreased by approximately 10% versus the comparable prior year period.Cost of sales decreased approximately 13% versus 2024. General and administrative expenses decreased approximately 20% year-over-year.In December 2025, the Company opened a new wellness retail location in New York City's Pennsylvania Station.In February 2026, XWELL entered int
- SECSEC Form 10-K filed by XWELL Inc.10-K - XWELL, Inc. (0001410428) (Filer)
- SECXWELL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - XWELL, Inc. (0001410428) (Filer)
- INSIDERDirector Weinstein Robert was granted 100,000 shares, increasing direct ownership by 87% to 215,231 units (SEC Form 4)4 - XWELL, Inc. (0001410428) (Issuer)
- INSIDERDirector Lebowitz Michael was granted 100,000 shares, increasing direct ownership by 90% to 211,122 units (SEC Form 4)4 - XWELL, Inc. (0001410428) (Issuer)
- INSIDERPresident and CEO Ernst Ezra was granted 100,000 shares, increasing direct ownership by 99% to 201,130 units (SEC Form 4)4 - XWELL, Inc. (0001410428) (Issuer)
- INSIDERDirector Bernstein Bruce was granted 100,000 shares, increasing direct ownership by 42% to 339,882 units (SEC Form 4)4 - XWELL, Inc. (0001410428) (Issuer)
- INSIDERDirector Wizenberg Gaelle Sandra was granted 100,000 shares, increasing direct ownership by 110% to 190,698 units (SEC Form 4)4 - XWELL, Inc. (0001410428) (Issuer)
- PRAI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning ToneDENVER, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets. From micro-cap transformation stories to cash-rich TechBio platforms, this morning's tape highlights companies positioning for scale in 2026 and beyond. Totaligent Targets APAC Biologics and Medical Tourism Totaligent (OTCID: TGNT) announced the execution of a binding Letter of Intent (LOI) with GloMed Solutions Limited Liability Company, a Japanese medical aesthetics and biologics distributor, to form a joint venture integrating Totaligent's recently announced Aetherium Medical platform. The agreement e
- SECXWELL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - XWELL, Inc. (0001410428) (Filer)
- PRXWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq RulesNEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 66,666,669 shares of common stock of the Company at an initial con
- PRXWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC MilestoneNEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (NASDAQ:XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance (TGS) program — part of the Biothreat Radar Detection System — which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity. Building on this milestone, the collaboration embeds AI-driven forecasting directly into frontline biosecuri
- PRXWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior AdvisorNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced the continued expansion of its global biosecurity strategy, leveraging its traveler-based pathogen surveillance capabilities to support international travel hubs and large-scale mass gathering events worldwide. To support this next phase of growth, XWELL announced today that Cindy Friedman, M.D., former CDC senior advisor and the founding director of CDC's Traveler-based Genomic Surveillance (TGS) program, will serve as a senior advisor to the Company. In this role, Dr. Friedman will provide strategic guidance on t
- SECXWELL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - XWELL, Inc. (0001410428) (Filer)
- PRXWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania StationNEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- XWELL (NASDAQ:XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, is excited to announce the opening of its newest location inside New York City's Pennsylvania Station—a major step in expanding the brand beyond airport terminals and into high-traffic city spaces. "Our entry into Penn Station marks a natural next step for XWELL as we continue evolving to meet people where they are," said Ezra Ernst, CEO of XWELL. "Wellness shouldn't be reserved for special occasions or hard-to-reach destinations. With this location, we're embedding accessible self-care into one of the busiest places in America—bringing
- SECXWELL Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - XWELL, Inc. (0001410428) (Filer)
- SECSEC Form DEF 14A filed by XWELL Inc.DEF 14A - XWELL, Inc. (0001410428) (Filer)
XWEL FAQ
4 questionsWhere does XWEL stock trade?
XWELL Inc. (XWEL) is listed on NASDAQ.What sector and industry is XWEL in?
XWELL Inc. operates in the Consumer Discretionary sector, Other Consumer Services industry.What companies are similar to XWEL?
Notable peers in the same industry include BAM (Brookfield Asset Management Inc), SE (Sea Limited), EDU (New Oriental Education & Technology Group Inc. Sponsored ADR r), IT (Gartner Inc.), SCI (Service Corporation International). Compare XWEL side-by-side with any of them on Quantisnow.How can I track XWEL on Quantisnow?
Quantisnow aggregates XWELL Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XWEL to receive live email and push alerts on every new disclosure.